The European database of suspected drug reaction reports is EudraVigilance, which also tracks reports of injuries and deaths following the experimental COVID-19 “vaccines.”

Here is what EudraVigilance states about their database:

This website was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects (also known as suspected adverse drug reactions). These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and by pharmaceutical companies that hold marketing authorisations (licences) for the medicines.

EudraVigilance is a system designed for collecting reports of suspected side effects. These reports are used for evaluating the benefits and risks of medicines during their development and monitoring their safety following their authorisation in the European Economic Area (EEA). EudraVigilance has been in use since December 2001.

This website was launched to comply with the EudraVigilance Access Policy, which was developed to improve public health by supporting the monitoring of the safety of medicines and to increase transparency for stakeholders, including the general public.

The Management Board of the European Medicines Agency first approved the EudraVigilance Access Policy in December 2010. A revision was adopted by the Board in December 2015 based on the 2010 pharmacovigilance legislation. The policy aims to provide stakeholders such as national medicines regulatory authorities in the EEA, the European Commission, healthcare professionals, patients and consumers, as well as the pharmaceutical industry and research organisations, with access to reports on suspected side effects.

Transparency is a key guiding principle of the Agency, and is pivotal to building trust and confidence in the regulatory process. By increasing transparency, the Agency is better able to address the growing need among stakeholders, including the general public, for access to information.

Their report through April 17, 2021 lists 7,766 deaths and 330,218 injuries following injections of four experimental COVID-19 shots:

• COVID-19 MRNA VACCINE MODERNA (CX-024414)
• COVID-19 MRNA VACCINE PFIZER-BIONTECH
• COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
• COVID-19 VACCINE JANSSEN (AD26.COV2.S)

A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. This subscriber has volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.

Here is the summary data through April 17, 2021.

Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer: 4,293 deaths and 144,607 injuries to 17/04/2021

• 10,754   Blood and lymphatic system disorders incl. 37 deaths
• 6,993     Cardiac disorders incl. 499 deaths
• 45           Congenital, familial and genetic disorders incl. 2 deaths
• 3,944     Ear and labyrinth disorders incl. 3 deaths
• 103        Endocrine disorders
• 4,388     Eye disorders incl. 5 deaths
• 32,024   Gastrointestinal disorders incl. 216 deaths
• 99,747   General disorders and administration site conditions incl. 1397 deaths
• 199        Hepatobiliary disorders incl. 15 deaths
• 3,165     Immune system disorders incl. 19 deaths
• 9,534     Infections and infestations incl. 512 deaths
• 3,653     Injury, poisoning and procedural complications incl. 79 deaths
• 7,166     Investigations incl. 161 deaths
• 2,407     Metabolism and nutrition disorders incl. 85 deaths
• 51,699   Musculoskeletal and connective tissue disorders incl. 44 deaths
• 133        Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 7 deaths
• 63,051   Nervous system disorders incl. 393 deaths
• 177        Pregnancy, puerperium and perinatal conditions incl. 7 deaths
• 76           Product issues
• 5,684     Psychiatric disorders incl. 60 deaths
• 885        Renal and urinary disorders incl. 62 deaths
• 911        Reproductive system and breast disorders incl. 1 death
• 13,181   Respiratory, thoracic and mediastinal disorders incl. 490 deaths
• 15,325   Skin and subcutaneous tissue disorders incl. 35 deaths
• 409        Social circumstances incl. 6 deaths
• 111        Surgical and medical procedures incl. 6 deaths
• 7,694     Vascular disorders incl. 152 deaths

Total reactions for the experimental mRNA vaccine mRNA-1273(CX-024414) from Moderna: 2,094 deaths and 15,979 injuries to 17/04/2021

• 766        Blood and lymphatic system disorders incl. 14 deaths
• 1,184     Cardiac disorders incl. 206 deaths
• 8             Congenital, familial and genetic disorders incl. 2 deaths
• 339        Ear and labyrinth disorders
• 20           Endocrine disorders
• 518        Eye disorders incl. 3 deaths
• 3,523     Gastrointestinal disorders incl. 75 deaths
• 11,366   General disorders and administration site conditions incl. 938 deaths
• 69           Hepatobiliary disorders incl. 3 deaths
• 439        Immune system disorders incl. 1 death
• 1,299     Infections and infestations incl. 107 deaths
• 707        Injury, poisoning and procedural complications incl. 41 deaths
• 5356     Investigations incl. 58 deaths
• 472        Metabolism and nutrition disorders incl. 42 deaths
• 5,163     Musculoskeletal and connective tissue disorders incl. 44 deaths
• 46           Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 7 deaths
• 6,834     Nervous system disorders incl. 215 deaths
• 44           Pregnancy, puerperium and perinatal conditions
• 8             Product issues
• 782        Psychiatric disorders incl. 31 deaths
• 271        Renal and urinary disorders incl. 20 deaths
• 96           Reproductive system and breast disorders incl. 1 death
• 2,019     Respiratory, thoracic and mediastinal disorders incl. 181 deaths
• 1,947     Skin and subcutaneous tissue disorders incl. 19 deaths
• 151        Social circumstances incl. 6 deaths
• 100        Surgical and medical procedures incl. 12 deaths
• 1,035     Vascular disorders incl. 68 deaths

Total reactions for the experimental vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 1,360 deaths and 169,386 injuries to 17/04/2021

• 4,740     Blood and lymphatic system disorders incl. 61 deaths
• 6,744     Cardiac disorders incl. 172 deaths
• 67           Congenital, familial and genetic disorders incl. 2 death
• 4,480     Ear and labyrinth disorders
• 127        Endocrine disorders incl. 2 deaths
• 6,983     Eye disorders incl. 5 deaths
• 52,560   Gastrointestinal disorders incl. 54 deaths
• 130,827General disorders and administration site conditions incl. 442 deaths
• 203        Hepatobiliary disorders incl. 6 deaths
• 1,666     Immune system disorders incl. 6 deaths
• 9,789     Infections and infestations incl. 88 deaths
• 3,736     Injury, poisoning and procedural complications incl. 16 deaths
• 8,792     Investigations incl. 19 deaths
• 6,575     Metabolism and nutrition disorders incl. 14 deaths
• 76,467   Musculoskeletal and connective tissue disorders incl. 13 deaths
• 125        Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 3 deaths
• 103,240Nervous system disorders incl. 207 deaths
• 88           Pregnancy, puerperium and perinatal conditions
• 42           Product issues
• 8,740     Psychiatric disorders incl. 10 deaths
• 1,609     Renal and urinary disorders incl. 10 deaths
• 1,688     Reproductive system and breast disorders
• 14,224   Respiratory, thoracic and mediastinal disorders incl. 130 deaths
• 21,280   Skin and subcutaneous tissue disorders incl. 9 deaths
• 330        Social circumstances incl. 3 deaths
• 351        Surgical and medical procedures incl. 10 deaths
• 7,427     Vascular disorders incl. 78 deaths

Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 19 deaths and 246 injuries to 17/04/2021

(No graph yet)

• 9             Blood and lymphatic system disorders incl. 1 death
• 29           Cardiac disorders incl. 5 deaths
• 1             Congenital, familial and genetic disorder
• 16           Ear and labyrinth disorders
• 1             Endocrine disorder
• 14           Eye disorders
• 61           Gastrointestinal disorders
• 154        General disorders and administration site conditions incl. 8 deaths
• 4             Hepatobiliary disorders
• 10           Immune system disorders
• 27           Infections and infestations
• 16           Injury, poisoning and procedural complications
• 40           Investigations
• 12           Metabolism and nutrition disorders
• 59           Musculoskeletal and connective tissue disorders
• 0             Neoplasms benign, malignant and unspecified (incl cysts and polyps)
• 138        Nervous system disorders incl. 1 death
• 0             Pregnancy, puerperium and perinatal conditions
• 1             Product issue
• 24           Psychiatric disorders
• 9             Renal and urinary disorders incl. 1 death
• 4             Reproductive system and breast disorders
• 49           Respiratory, thoracic and mediastinal disorders incl. 1 death
• 28           Skin and subcutaneous tissue disorders
• 4             Social circumstances
• 4             Surgical and medical procedures
• 44           Vascular disorders incl. 2 deaths

This is public information funded by the European Medicines Agency (EMA), and anyone can use the EudraVigilance system and verify this data.

Denmark and Norway have completely suspended use of the AstraZeneca experimental COVID-19 shots.

A statement issued by the Norwegian Institute of Public Health stated that the AstraZeneca COVID “vaccine” is more dangerous than COVID itself, especially for young people.

The EMA continues to recommend it. They did, however, add a safety warning to the J&J shots, due to fatal blood clots.